You are here
CERID Bibliography
Export 94 results:
[ Author] Title Type Year Filters: First Letter Of Last Name is P [Clear All Filters]
CD28 promotes CD4+ T cell clonal expansion during infection independently of its YMNM and PYAP motifs. J Immunol. 2012 ;189(6):2909-17.
. Tracking antigen-specific CD4+ T cells throughout the course of chronic Leishmania major infection in resistant mice. Eur J Immunol. 2013 ;43(2):427-38.
. Granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, and other immunomodulatory therapies for the treatment of infectious diseases in solid organ transplant recipients. Curr Opin Organ Transplant. 2008 ;13(6):575-80.
. Biomarkers of endothelial activation/dysfunction in infectious diseases. Virulence. 2013 ;4(6):507-16.
. Posaconazole: A new agent for the prevention and management of severe, refractory or invasive fungal infections. Can J Infect Dis Med Microbiol. 2008 ;19(4):297-305.
. Dysregulation of Angiopoietin 1 and 2 in Escherichia coli O157:H7 Infection and the Hemolytic-Uremic Syndrome. J Infect Dis. 2013 ;208(6):929-33.
. Systemic dysregulation of angiopoietin-1/2 in streptococcal toxic shock syndrome. Clin Infect Dis. 2011 ;52(8):e157-61.
. Enterohemorrhagic Escherichia coli Infections and the Hemolytic-Uremic Syndrome. Med Clin North Am. 2013 ;97(4):681-95, xi.
. Tumor necrosis factor-alpha inhibitor-induced lupus-like syndrome presenting as fever of unknown origin in a liver transplant recipient: case report and concise review of the literature. Transplant Proc. 2008 ;40(5):1768-70.
. Colony-stimulating factors in the prevention and management of infectious diseases. Infect Dis Clin North Am. 2011 ;25(4):803-17.
. Primary cutaneous mucormycosis in a lung transplant recipient: case report and concise review of the literature. Transpl Infect Dis. 2008 ;10(6):419-25.
. The Ames test: a look at the Salmonella/mammalian microsome mutagenicity test. Vet Hum Toxicol. 1980 ;22(1):23-5.
. Insights into mechanisms of bacterial antigenic variation derived from the complete genome sequence of Anaplasma marginale. Ann N Y Acad Sci. 2006 ;1078:15-25.
. The immunoprotective Anaplasma marginale major surface protein 2 is encoded by a polymorphic multigene family. Infect Immun. 1994 ;62(9):3808-16.
. Presence of common antigens, including major surface protein epitopes, between the cattle (intraerythrocytic) and tick stages of Anaplasma marginale. Infect Immun. 1985 ;50(3):881-6.
. A note on the growth of some micro-organisms in stored bovine colostrum. J Dairy Res. 1972 ;39(2):227-30.
. Rickettsial entry into host cells: finding the keys to unlock the doors. Infect Immun. 2012 ;80(11):3746-7.
. Antigenic variation in the persistence and transmission of the ehrlichia Anaplasma marginale. Microbes Infect. 2000 ;2(2):167-76.
. The cellular basis of GABA(B)-mediated interhemispheric inhibition. Science. 2012 ;335(6071):989-93.
. Immunization of cattle with a 36-kilodalton surface protein induces protection against homologous and heterologous Anaplasma marginale challenge. Infect Immun. 1988 ;56(6):1526-31.
. Feline upper respiratory disease: a review. Vet Med Small Anim Clin. 1980 ;75(10):1556-8.
. Selection for simple major surface protein 2 variants during Anaplasma marginale transmission to immunologically naïve animals. Infect Immun. 2007 ;75(3):1502-6.
. Molecular basis for vaccine development against anaplasmosis and babesiosis. Vet Parasitol. 1995 ;57(1-3):233-53.
. Immunization with an isolate-common surface protein protects cattle against anaplasmosis. Science. 1986 ;231(4743):1299-302.
. .